Therapeutic value of interleukin-3 given alone or in combination with other cytokines
Ganser, A.; Hoelzer, D.
Nouvelle Revue Francaise d'Hematologie 35(3): 245-246
1993
ISSN/ISBN: 0029-4810 PMID: 8337137 Document Number: 408232
Document emailed within 1 workday
Related Documents
Truitt, G.A.; Brunda, M.J.; Levitt, D.; Anderson, T.D.; Sherman, M.I. 1989: The therapeutic activity in cancer of IL-2 in combination with other cytokines Cancer Surveys 8(4): 875-889Larsen, C.; Zachariae, C.; Mukaida, N.; Anderson, A.; Yamada, M.; Oppenheim, J.; Matsushima, K. 1990: Proinflammatory cytokines interleukin 1 and tumor necrosis factor induce cytokines that are chemotactic for neutrophils, T cells and monocytes Progress in Clinical and Biological Research 349: 419-431
Yokota, T. 2005: Class i cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 4): 187-192
Bubeník, J.; Símová, J.; Zeuthen, J.; Diamant, M.; Jandlová, T.; Bubeníková, D. 1994: Gene therapy of plasmacytoma: comparison of the therapeutic efficacy of tumour cells transduced with the interleukin-2, interleukin-4, or interleukin-6 genes Folia Biologica 40(1-2): 29-36
Kilpinen, S.; Huhtala, H.; Hurme, M. 2002: The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals European Cytokine Network 13(1): 66-71
Nishi, K.; Nishi, O.; Omoto, Y. 1992: The synthesis of cytokines by human lens epithelial cells--interleukin 1 (IL-1), tumor necrosis factor (TNF) interleukin 6 (IL-6), and epidermal growth factor (EGF) Nippon Ganka Gakkai Zasshi 96(6): 715-720
Tushinski, R.J.; Larsen, A.; Park, L.S.; Spoor, E.; Williams, D.E.; Mochizuki, D.Y. 1991: Interleukin 4 alone or in combination with interleukin 1 stimulates 3T3 fibroblasts to produce colony-stimulating factors Experimental Hematology 19(4): 238-244
Matveeva, L.V.; Mosina, L.M. 2012: The role of interleukin-1 and associated cytokines in gastric carcinogenesis Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 11: 59-65
Yoshizaki, K. 1990: Clinical significance of cytokines-interleukin 6 in disease Rinsho Byori. Japanese Journal of Clinical Pathology 38(4): 375-379
Wolf, R.E.; Brelsford, W.G.; Hall, V.C.; Adams, S.B. 1992: Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis Journal of Rheumatology 19(4): 524-528
Kunkel, S.L.; Strieter, R.M.; Chensue, S.W.; Basha, M.; Standiford, T.; Ham, J.; Remick, D.G. 1990: Tumor necrosis factor-alpha, interleukin-8 and chemotactic cytokines Progress in Clinical and Biological Research 349: 433-444
Koyasu, S. 1988: Cytokines and receptors--their functions, structures and cloning of code genes. Interleukin-3 Nihon Rinsho. Japanese Journal of Clinical Medicine 46(5): 1008-1013
Holán, V.; Minowada, J. 1993: Enhancement of interleukin-2 (IL-2) production by 6 different cytokines: heterogeneity among IL-2 producing T cell clones Folia Biologica 39(1): 1-13
Jovanovic, D.V.; Di Battista, J.A.; Martel-Pelletier, J.; Reboul, P.; He, Y.; Jolicoeur, F.C.; Pelletier, J.P. 2001: Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages Journal of Rheumatology 28(4): 712-718
Locker, G.J.; Kofler, J.; Stoiser, B.; Wilfing, A.; Wenzel, C.; Wögerbauer, M.; Steger, G.G.; Zielinski, C.C.; Mader, R.; Burgmann, H. 2000: Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2 European Cytokine Network 11(3): 391-396
Nowak, C.; Arnold, W.; Henneberger, G.; Tanneberger, S. 1980: Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems Archiv für Geschwulstforschung 50(8): 747-757
Imoto, S.; Oomoto, Y.; Murata, K.; Das, H.; Murayama, T.; Kajimoto, K.; Sugimoto, T.; Gomyo, H.; Nakagawa, T.; Nishimura, R.; Koizumi, T. 2000: Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease International Journal of Hematology 72(1): 92-97
Szekanecz, Z.; Szegedi, G. 1998: Cytokines in rheumatoid arthritis: new therapeutic possibilities Orvosi Hetilap 139(14): 819-823
Shaarawy, M.; Zaki, S.; Sheiba, M.; El, A.M.-Minawi 2003: Circulating Levels of Osteoclast Activating Cytokines, Interleukin-11 and Transforming Growth Factor-ß2, as Valuable Biomarkers for the Assessment of Bone Turnover in Postmenopausal Osteoporosis Clinical Laboratory 49(11-12): 625-636
Quesniaux, V. 1994: Cytokines: regulators of hematopoiesis with promising therapeutic potential Praxis 83(45): 1247-1249